A 4-mm Needle Reduces the Risk of Intramuscular Injections Without Increasing Backflow to Skin Surface in Lean Diabetic Children and Adults
- Niels H. Birkebaek, MD, PHD1,
- Jan Solvig, MD2,
- Birtha Hansen, CAND CUR3,
- Christina Jorgensen, MSC PHARM4,
- Jorgen Smedegaard, MD4 and
- Jens S. Christiansen, MD, DMSC3
- 1Pediatric Department, Aarhus University Hospital, Skejby, Aarhus, Denmark
- 2Radiologic Department, Aarhus University Hospital, Skejby, Aarhus, Denmark
- 3Medical Department M, Aarhus University Hospital, Aarhus, Denmark
- 4Novo Nordisk A/S, Copenhagen, Denmark
- Corresponding author: Niels H. Birkebaek, nbb{at}sks.aaa.dk
Unintended intramuscular insulin injection increases the variation in the insulin absorption rate, thereby increasing the risk of hypoglycemia. To reduce the risk of intramuscular injection, shorter injection needles should be tested, particularly in lean patients (1–3). The objective of this study was to measure the distance from skin surface to muscle fascia in lean diabetic patients and to determine whether using an experimental 4-mm needle reduces the frequency of intramuscular injections as compared with a 6-mm needle. Further, this study tested whether the backflow of simulated insulin (test medium) was unchanged using the new 4-mm needle as compared with the 6-mm needle.
We included 21 lean children (16 male) and …
